Biotech Founder and CEO Clay Siegall

Founder and CEO of Seattle Genetics, Clay Siegall is a well-known name in the world of biotech. He has been in the industry for over 24 years. He has been involved in a number of notable endeavors, such as leading biotech startups and pursuing cancer research. He has also been awarded a number of awards and accolades for his achievements.

During his career, he has authored more than 70 publications. He has also been named to several epoch making lists. Among these lists, he has been ranked 87th on the Forbes’ Innovative Leaders list in 2019. In 2019, he was paid $15 million, which made him the highest paid CEO in Washington. He has also earned a net worth of $150 million.

In the past, Clay Siegall has been married for several years. He has a wife named Nellie, who is about 15 years younger than him. She was born on June 1975. In their marriage, they had an abusive relationship. The pair were also allegedly in physical combat. In one incident, Clay dragged his wife around the house. She claims that he also physically assaulted her.

The police were notified of the incident after a 911 call was made from the Siegall’s California home. After a brief arrest, he was released. The couple was then reconciled five months later. In the meantime, Siegall had a series of run-ins with the police.

The arrest wasn’t the first time that the police visited the home. In fact, the police had been in the house numerous times during the three-year-long marriage. When the police arrived, Siegall was asleep. The next day, he was released.

During his tenure at Seagen, he earned the title of the highest-paid CEO in Washington state. He was paid $16.5 million in 2020. The base salary was also up 3.5% from the previous year. He was also given a severance package of 1.5 times his salary. This package was set to be paid out in March.

He is also a member of the Ultragenyx Pharmaceutical board and Mirna Therapeutics Inc. He has also been named to the board of five other companies, including Cascadian Therapeutics, where he serves as chair. He is also a board member of Alder Biopharmaceuticals and Seagen Inc. He has also been on a number of charity events, including the Cancer Research Alliance’s Celebrity Golf Classic.

He is also the chairman of Seagen Inc., a Bothell-based biotech company. It is one of the 20 largest companies in Washington. During the first quarter of the year, the company reported strong financial results. It also said that it had acquired a company that manufactures a tyrosine kinase inhibitor for HER2 cancers.

The Seattle Genetics CEO received a compensation package of $18.1 million in 2018. The compensation package included incentive grants of $2 million and an increase in his stock award from $8.22 million in 2017. He is reportedly up for a $1 million incentive grant in the coming months.